A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response

This publication has 28 references indexed in Scilit:

• Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
  JNCI: Journal of the National Cancer Institute, 2011
• Use of antineoplastic agents in patients with cancer who have HIV/AIDS
  The Lancet Oncology, 2011
• Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2010
• Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
  Cancer Research, 2009
• Clinical target promiscuity: lessons from ras molecular trials
  Cancer and Metastasis Reviews, 2008
• Liver Enzymes Elevation and Immune Reconstitution Among Treatment-Naïve HIV-Infected Patients Instituting Antiretroviral Therapy
  The American Journal of the Medical Sciences, 2007
• HIV Protease Inhibitors Block Akt Signaling and Radiosensitize Tumor Cells Both In vitro and In vivo
  Cancer Research, 2005
• Targeting tumor cells by enhancing radiation sensitivity
  Genes, Chromosomes and Cancer, 2003
• Intensive chemotherapy with cyclophosphamide, doxorubicin, high‐dose methotrexate/ifosfamide, etoposide, and high‐dose cytarabine (CODOX‐M/IVAC) for human immunodeficiency virus–associated Burkitt lymphoma
  Cancer, 2003
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999